✦ LIBER ✦

A randomised controlled trial of adenine arabinoside 5′-monophosphate (ARA-AMP) in chronic hepatitis B virus infection

✍ Scribed by Weller, I.V.D.

Book ID: 122978634
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 258 KB
Volume: 3
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(86)80107-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disappearance of serum hepatitis B virus

Disappearance of serum hepatitis B virus DNA by polymerase chain reaction after adenine arabinoside 5‘-monophosphate therapy in chronic hepatitis B

✍ M. Buti; F. Rodriguez-Frlas; J. Genesca; A. Arranz; R. Jardi; R. Esteban; J. Gua 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB

Randomized controlled trial of adenine a

Randomized controlled trial of adenine arabinoside 5′-monophosphate in chronic active hepatitis B: Comparison of the efficacy in heterosexual and homosexual patients

✍ Patrick Marcellin; Denis Ouzan; Françoise Degos; Christian Brechot; Etienne-Henr 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 1 views

Twenty-two heterosexuals and 2 1 homosexuals with chronic active hepatitis B and who had HBsAg, HBeAg and hepatitis B virus DNA in serum were randomized separately to receive adenine arabinoside monophosphate or placebo. In the 10 heterosexuals and nine homosexuals who received placebo, no change in

A randomised controlled trial of recombi

A randomised controlled trial of recombinant interferon-γ in chinese patients with chronic hepatitis B virus infection

✍ Johnson Y. N. Lau; Dr. C. L. Lai; P. C. Wu; H. T. Chung; Anna S. F. Lok; H. J. L 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB

## Abstract Nineteen Chinese patients with chronic hepatitis B virus (HBV) infection, seropositive for HBV e antigen (HBeAg) and HBV DNA on at least three occasions in 6 months, were randomised to receive either recombinant human interferongamma (rlFNγ) 0.1 mg/m^2^ intramuscularly thrice weekly for

A randomised controlled trial with human

A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection

✍ Barbara, L.; Mazzella, G.; Baraldini, M.; Gasbarrini, G.; Giungi, F.; Malavolti, 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Efficacy and safety of lactosaminated hu

Efficacy and safety of lactosaminated human serum albumin-adenine arabinoside monophosphate in chronic hepatitis B patients non-responders to interferon therapy: a randomised clinical trial

✍ Jean-Pierre Zarski; Karl Barange; Claude Souvignet; Marco Bertini; Patrick Marce 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Controlled clinical trial of acyclovir i

Controlled clinical trial of acyclovir in chronic hepatitis B virus infection

✍ Dr. Graeme J. M. Alexander; Elizabeth A. Fagan; John E. Hegarty; Adrian L. W. F. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB 👁 1 views

A randomised, controlled trial comparing acyclovir, 45 mg/kg/day as a continuous IV infusion for 28 days, with no other therapy, was carried out in 30 stable HBsAg carriers seropositive for HBeAg for more than 6 months. Twenty-eight had hepatitis B virus DNA-polymerase activity and/or hepatitis B vi